What is the share price of Supha Pharmachem Ltd (SUPHA) today?
The share price of SUPHA as on 2nd March 2026 is ₹0.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Supha Pharmachem Ltd (SUPHA) share?
The past returns of Supha Pharmachem Ltd (SUPHA) share are- Past 1 week: -38.20%
- Past 1 month: -38.20%
- Past 3 months: -48.11%
- Past 6 months: -58.33%
- Past 1 year: -68.93%
- Past 3 years: -70.43%
- Past 5 years: 83.33%
What are the peers or stocks similar to Supha Pharmachem Ltd (SUPHA)?
The peers or stocks similar to Supha Pharmachem Ltd (SUPHA) include:What is the market cap of Supha Pharmachem Ltd (SUPHA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Supha Pharmachem Ltd (SUPHA) is ₹48.51 Cr as of 2nd March 2026.What is the 52 week high and low of Supha Pharmachem Ltd (SUPHA) share?
The 52-week high of Supha Pharmachem Ltd (SUPHA) is ₹1.94 and the 52-week low is ₹0.55.What is the PE and PB ratio of Supha Pharmachem Ltd (SUPHA) stock?
The P/E (price-to-earnings) ratio of Supha Pharmachem Ltd (SUPHA) is 22.77. The P/B (price-to-book) ratio is 1.11.Which sector does Supha Pharmachem Ltd (SUPHA) belong to?
Supha Pharmachem Ltd (SUPHA) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Supha Pharmachem Ltd (SUPHA) shares?
You can directly buy Supha Pharmachem Ltd (SUPHA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Supha Pharmachem Ltd
SUPHA Share Price
BSE₹0.5519.12% (-0.13)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SUPHA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SUPHA Performance & Key Metrics
SUPHA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.11 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 29.39 | 3.36 | 1.53% |
SUPHA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SUPHA Company Profile
Supha Pharmachem Ltd trades and distributes pharmaceutical raw materials including advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialty chemicals such as Isopropyl Alcohol, Cyclohexane, Diisopropyl Amine, Ethyl Acetate, Hydrazine Hydrate, and others for the pharmaceutical industry.
FLUOROCHEM
PE Ratio
66.72
66.72
1Y Return
3.67%
3.67%
Buy Reco %
66.67
66.67
NAVINFLUOR
PE Ratio
111.33
111.33
1Y Return
63.82%
63.82%
Buy Reco %
75.00
75.00
AARTIIND
PE Ratio
47.45
47.45
1Y Return
13.49%
13.49%
Buy Reco %
85.00
85.00
VINATIORGA
PE Ratio
36.14
36.14
1Y Return
8.11%
8.11%
Buy Reco %
72.73
72.73
ANURAS
PE Ratio
148.52
148.52
1Y Return
71.68%
71.68%
Buy Reco %
42.86
42.86
SUPHA Forecast
SUPHA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SUPHA
SUPHA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
SUPHA Income Statement
SUPHA Income Statement
Quarterly Normal View
| Quarter | mar 2025 | jun 2025 | sep 2025 | |||
|---|---|---|---|---|---|---|
| Total Revenue | 264.98 | 116.84 | 114.31 | |||
Operating & Other expenses | 264.78 | 111.50 | 103.69 | |||
EBITDA | 0.20 | 5.34 | 10.62 | |||
| Depreciation/Amortization | 0.01 | 0.00 | 0.00 | |||
| PBIT | 0.19 | 5.34 | 10.62 | |||
| Interest & Other Items | 1.59 | -0.36 | 0.19 | |||
| PBT | -1.40 | 5.70 | 10.43 | |||
| Taxes & Other Items | 0.64 | 1.06 | 1.81 | |||
| Net Income | -2.04 | 4.64 | 8.62 | |||
| EPS | -0.03 | 0.05 | 0.10 |
SUPHA Company Updates
SUPHA Stock Peers
SUPHA Past Performance & Peer Comparison
SUPHA Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Supha Pharmachem Ltd | 22.77 | 1.11 | — |
| Gujarat Fluorochemicals Ltd | 66.72 | 4.99 | 0.09% |
| Navin Fluorine International Ltd | 111.33 | 12.23 | 0.11% |
| Aarti Industries Ltd | 47.45 | 2.80 | 0.23% |
SUPHA Stock Price Comparison
Compare SUPHA with any stock or ETFCompare SUPHA with any stock or ETF
SUPHA
SUPHA Holdings
SUPHA Shareholdings
SUPHA Promoter Holdings Trend
SUPHA Promoter Holdings Trend
SUPHA Institutional Holdings Trend
SUPHA Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 2.02%
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.70%
SUPHA Shareholding Pattern
SUPHA Shareholding Pattern
SUPHA Shareholding History
SUPHA Shareholding History
Foreign Institutions
smallcases containing SUPHA stock
smallcases containing SUPHA stock
Looks like this stock is not in any smallcase yet.
SUPHA Events
SUPHA Events
SUPHA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUPHA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SUPHA Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUPHA has not given any dividends in last 5 years
SUPHA Dividends
SUPHA Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSUPHA Stock News & Opinions
SUPHA Stock News & Opinions
Articles & Videos
Corporate
Remedium Lifecare postpones board meeting
Remedium Lifecare has postponed the meeting of the Board of Directors which was scheduled to be held on 25 February 2026. The meeting will now be held on 9 March 2026.Powered by Capital Market - Live
4 days agoCapital Market - Live
Corporate
Remedium Lifecare schedules board meeting
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Remedium Lifecare standalone net profit declines 96.07% in the September 2025 quarter
Net profit of Remedium Lifecare declined 96.07% to Rs 0.07 crore in the quarter ended September 2025 as against Rs 1.78 crore during the previous quarter ended September 2024. Sales declined 65.79% to Rs 8.58 crore in the quarter ended September 2025 as against Rs 25.08 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.5825.08 -66 OPM %-34.8517.78 - PBDT0.072.47 -97 PBT0.072.46 -97 NP0.071.78 -96 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Remedium Lifecare to convene board meeting
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Remedium Lifecare to hold board meeting
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 22 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Remedium Lifecare schedules AGM
Remedium Lifecare announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Remedium Lifecare reports standalone net loss of Rs 0.37 crore in the June 2025 quarter
Net loss of Remedium Lifecare reported to Rs 0.37 crore in the quarter ended June 2025 as against net profit of Rs 1.64 crore during the previous quarter ended June 2024. Sales declined 76.36% to Rs 18.37 crore in the quarter ended June 2025 as against Rs 77.70 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales18.3777.70 -76 OPM %-22.920.50 - PBDT-0.372.28 PL PBT-0.372.27 PL NP-0.371.64 PL Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Remedium Lifecare to declare Quarterly Results
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 4 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Remedium Lifecare reports standalone net loss of Rs 2.64 crore in the March 2025 quarter
Net Loss of Remedium Lifecare reported to Rs 2.64 crore in the quarter ended March 2025 as against net loss of Rs 53.72 crore during the previous quarter ended March 2024. Sales declined 94.21% to Rs 81.57 crore in the quarter ended March 2025 as against Rs 1408.49 crore during the previous quarter ended March 2024. For the full year,net profit declined 95.33% to Rs 1.53 crore in the year ended March 2025 as against Rs 32.73 crore during the previous year ended March 2024. Sales declined 94.49% to Rs 222.50 crore in the year ended March 2025 as against Rs 4041.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales81.571408.49 -94 222.504041.71 -94 OPM %-1.45-2.49 --0.810.82 - PBDT-2.11-35.99 94 3.7050.51 -93 PBT-2.12-36.00 94 3.6650.45 -93 NP-2.64-53.72 95 1.5332.73 -95 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Remedium Lifecare announces board meeting date
Remedium Lifecare will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant